Business Standard

CordenPharma extends Moderna deal to supply lipids to produce Covid vaccine

The expanded agreement will be effective immediately to help meet Moderna's increasing demand over the coming months

Pharma, medicine, drugs, Pharmaceuticals
Premium

This expansion will increase supply of lipid excipients used to manufacture our mRNA products

Agencies
Pharmaceutical company CordenPharma has extended its agreement with Moderna Inc to supply large volumes of lipids used to produce Moderna's Covid-19 vaccine candidate.

The expanded agreement will be effective immediately to help meet Moderna's increasing demand over the coming months, the Reuters reported.


"This expansion will increase supply of lipid excipients used to manufacture our mRNA products," Moderna's chief technical operations and quality officer, Juan Andres, said.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 28 2020 | 1:14 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com